Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Obesity and insulin resistance: lessons learned from the Pima Indians.

Lillioja S, Bogardus C.

Diabetes Metab Rev. 1988 Aug;4(5):517-40. Review.

PMID:
3061759
2.
3.
5.

Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.

Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA, Baier LJ, Tataranni PA, Silver K, Bogardus C.

Diabetes. 2003 Jun;52(6):1544-50.

6.
7.

High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.

Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA.

Diabetes. 2004 May;53(5):1279-84. Erratum in: Diabetes. 2004 Sep;53(9):2518. Volarova de Courten, B [corrected to Vozarova de Courten, B].

8.

Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.

Stefan N, Weyer C, Levy-Marchal C, Stumvoll M, Knowler WC, Tataranni PA, Bogardus C, Pratley RE.

Metabolism. 2004 Jul;53(7):904-11.

PMID:
15254885
9.

Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion.

Gautier JF, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE.

Diabetologia. 1999 Jan;42(1):28-34.

PMID:
10027574
10.

Relationship between insulin-mediated glucose disposal and lipid metabolism in man.

Lillioja S, Bogardus C, Mott DM, Kennedy AL, Knowler WC, Howard BV.

J Clin Invest. 1985 Apr;75(4):1106-15.

11.

Studies of the etiology of obesity in Pima Indians.

Howard BV, Bogardus C, Ravussin E, Foley JE, Lillioja S, Mott DM, Bennett PH, Knowler WC.

Am J Clin Nutr. 1991 Jun;53(6 Suppl):1577S-1585S.

PMID:
1827703
12.
13.

Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.

14.

Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.

Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Lönnroth P, Knuuti J, Ferrannini E, Nuutila P.

Diabetes. 2005 Sep;54(9):2720-6.

15.

Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.

Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, Vettor R.

Metabolism. 1997 Feb;46(2):123-9.

PMID:
9030815
16.

[Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].

Bao YQ, Jia WP, Chen L, Lu JX, Zhu M, Lu W, Xiang KA.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):740-4. Chinese.

17.

Clinical aspects of leptin.

Sinha MK, Caro JF.

Vitam Horm. 1998;54:1-30. Review.

PMID:
9529971
18.

The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals.

Cornier MA, Bergman BC, Bessesen DH.

Metabolism. 2006 Sep;55(9):1207-14.

PMID:
16919540
19.

[Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].

Chen L, Xiang KS, Jia WP, Lu JX, Bao YQ, Lu HJ.

Zhonghua Yi Xue Za Zhi. 2005 Jun 8;85(21):1456-9. Chinese.

PMID:
16061021
20.

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

Diabetes. 2002 Jun;51(6):1884-8.

Supplemental Content

Support Center